2 bn doses of Covid-19 vaccine to be ready by next yr: WHO chief scientist

Swaminathan said that WHO recommends immunizing people at risk first, including the elderly and those with underlying conditions like diabetes or respiratory disease, as well as key workers

Soumya Swaminathan
Soumya Swaminathan. Photo courtesy: @doctorsoumya
AP | PTI New Delhi
2 min read Last Updated : Jun 18 2020 | 8:15 PM IST
The chief scientist at the World Health Organization says the agency hopes there will be about 2 billion doses of a vaccine against Covid-19 by the end of next year that would be reserved for priority populations.

Dr Soumya Swaminathan told a press briefing: It's a big if because we don't have any vaccine that's proven. She said that because of the numerous vaccine candidates currently being tested, WHO hoped at least some might prove ready for use next year.

Swaminathan said that WHO recommends immunizing people at risk first, including the elderly and those with underlying conditions like diabetes or respiratory disease, as well as key workers.


But Swaminathan noted that there was still no strategy regarding any possible global distribution of Covid-19 vaccines. WHO will propose these solutions, she said. Countries need to agree and come to a consensus. That's the only way this can work.

Numerous developed countries including Britain, France, the Netherlands, Germany and the U.S. have already struck deals with pharmaceuticals to secure vaccine supplies for their citizens first.

WHO and partners have called for drugmakers to suspend their patent rights on any effective Covid-19 vaccine and for billions of dollars to buy vaccines for developing countries.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusWHO’s Soumya SwaminathanCoronavirus Vaccine

Next Story